Literature DB >> 28349302

A Mutant Sumo Facilitates Quick Plasmid Construction for Expressing Proteins with Native N-termini After Tag Removal.

Yuzhu Zhang1, Yuting Fan2,3.   

Abstract

Sumo is one of the fusion tags commonly used to enhance the expression and the solubility of recombinant proteins. One advantage of using sumo is that the removal of the sumo tag is highly specific because its recognition by a sumo protease is determined by its structural characteristics, instead of the sequence of a short peptide. Recently, it was reported that sumo could also be used as a protease recognition site to facilitate the removal of other fusion tags, such as MBP, when sumo itself is not suitable to enhance the solubility of a particular target protein. Using sumo as a recognition site is highly desirable when the target protein needs to have its native N terminus. However, constructing such a plasmid involves more than one cloning step because the N terminus of the target protein needs to be the next residue after the diglycine of sumo. Here, we report the construction of a new vector with a mutant sumo tag. The incorporation of a Pvu II site near the 3' end of tag coding sequence enables quick construction of plasmids for producing proteins with native termini. Its usage includes producing recombinant food allergens for studying conformational IgE epitopes.

Entities:  

Keywords:  Sumo; Tandem affinity purification; ULP; pTS1

Mesh:

Substances:

Year:  2017        PMID: 28349302     DOI: 10.1007/s12033-017-9998-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  22 in total

1.  Influence of the amino acid residue downstream of (Asp)4Lys on enterokinase cleavage of a fusion protein.

Authors:  T Hosfield; Q Lu
Journal:  Anal Biochem       Date:  1999-04-10       Impact factor: 3.365

2.  GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes.

Authors:  A J Walhout; G F Temple; M A Brasch; J L Hartley; M A Lorson; S van den Heuvel; M Vidal
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.

Authors:  E Mossessova; C D Lima
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

Review 4.  Enhancement of soluble protein expression through the use of fusion tags.

Authors:  Dominic Esposito; Deb K Chatterjee
Journal:  Curr Opin Biotechnol       Date:  2006-06-15       Impact factor: 9.740

5.  An in vitro recombination method to convert restriction- and ligation-independent expression vectors.

Authors:  Feng Guo; Ming-Yi Chiang; Yingtong Wang; Yu-Zhu Zhang
Journal:  Biotechnol J       Date:  2008-03       Impact factor: 4.677

6.  Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency.

Authors:  R B Kapust; J Tözsér; J D Fox; D E Anderson; S Cherry; T D Copeland; D S Waugh
Journal:  Protein Eng       Date:  2001-12

7.  High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners.

Authors:  Wanhua Guo; Lin Cao; Zhijun Jia; Gang Wu; Teng Li; Fengxia Lu; Zhaoxin Lu
Journal:  Protein Expr Purif       Date:  2011-02-01       Impact factor: 1.650

8.  SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins.

Authors:  Michael P Malakhov; Michael R Mattern; Oxana A Malakhova; Mark Drinker; Stephen D Weeks; Tauseef R Butt
Journal:  J Struct Funct Genomics       Date:  2004

9.  Fast and sensitive colloidal coomassie G-250 staining for proteins in polyacrylamide gels.

Authors:  Nadine Dyballa; Sabine Metzger
Journal:  J Vis Exp       Date:  2009-08-03       Impact factor: 1.355

10.  Inteins and affinity resin substitutes for protein purification and scale up.

Authors:  Mahmoud Reza Banki; David W Wood
Journal:  Microb Cell Fact       Date:  2005-11-11       Impact factor: 5.328

View more
  1 in total

1.  DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD.

Authors:  Christian Klingler; Jon Ashley; Ke Shi; Adeline Stiefvater; Michael Kyba; Michael Sinnreich; Hideki Aihara; Jochen Kinter
Journal:  FASEB J       Date:  2020-02-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.